Early respiratory decline around diagnosis and short-term post-landmark outcomes in amyotrophic lateral sclerosis: a 6-month landmark cohort study
Neurological Sciences · 2026
DOI: 10.1007/s10072-026-09166-2 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Neurological Sciences, 2026. Verfasst von Kazuhiro Horiuchi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hakodate Municipal Hospital, 1-10-1 Minato-cho, Hakodate, Hokkaido, Japan. horiuchi-kazuhiro@hotmail.co.jp. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: In amyotrophic lateral sclerosis (ALS), respiratory decisions rely on serial trends rather than a single value. We evaluated whether early respiratory decline around diagnosis provides prognostic information in a real-world landmark framework. METHODS: This single-center retrospective cohort screened 94 consecutive patients diagnosed between April 2019 and December 2025. A 6-month landmark was used. Early decline was estimated from %FVC values between - 30 and + 180 days around diagnosis. The primary model included age and early %FVC decline; robustness analyses included time-varying Cox, piecewise Cox, RMST, included-vs-excluded comparison, death-only analysis, and slope-quality filtering. RESULTS: Of 94 screened patients, 62 met baseline eligibility, 56 had calculable early slope, and 45 entered the landmark cohort; 28 post-landmark composite events occurred. In the Cox model, faster early %FVC decline was associated with higher hazard of death or invasive mechanical ventilation via tracheostomy (HR 1.33 per 1%/month faster decline, 95% CI 1.14-1.55, p < 0.001). PH diagnostics suggested non-proportionality (%FVC p = 0.031; NIV p = 0.034 in the expanded model), so this HR was interpreted as an average follow-up association and complemented by PH-robust analyses. The signal was stronger early than late, remained consistent in a death-only analysis, and favored the slower-decline group by RMST at 24 and 36 months. CONCLUSIONS: In this selected measurement-capable landmark cohort, early respiratory decline provided a clinically meaningful short-to-medium term prognostic signal for post-landmark adverse outcomes. External validation is required before broader generalization beyond measurement-capable landmark populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Hakodate Municipal Hospital, 1-10-1 Minato-cho, Hakodate, Hokkaido, Japan. horiuchi-kazuhiro@hotmail.co.jp.
- Department of Neurology, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
- Department of Neurology, Hakodate Municipal Hospital, 1-10-1 Minato-cho, Hakodate, Hokkaido, Japan.
Zitieren
APA
Horiuchi, K., Nakamura, S., Ishikawa, K., Nunomura, S., Yamada, K., Inoue, T., Oiwa, K., Fujii, S., Oshima, Y., Kudo, A., & Yabe, I. (2026). Early respiratory decline around diagnosis and short-term post-landmark outcomes in amyotrophic lateral sclerosis: a 6-month landmark cohort study. Neurological Sciences. https://doi.org/10.1007/s10072-026-09166-2
Vancouver
Horiuchi K, Nakamura S, Ishikawa K, Nunomura S, Yamada K, Inoue T, et al. Early respiratory decline around diagnosis and short-term post-landmark outcomes in amyotrophic lateral sclerosis: a 6-month landmark cohort study. Neurological Sciences. 2026. doi:10.1007/s10072-026-09166-2
BibTeX
@article{Horiuchi2026,
author = {Horiuchi, Kazuhiro and Nakamura, Shuntaro and Ishikawa, Kaede and Nunomura, Sumire and Yamada, Kazuki and Inoue, Takashi and Oiwa, Kei and Fujii, Shintaro and Oshima, Yuki and Kudo, Akihiko and Yabe, Ichiro},
title = {Early respiratory decline around diagnosis and short-term post-landmark outcomes in amyotrophic lateral sclerosis: a 6-month landmark cohort study},
journal = {Neurological Sciences},
year = {2026},
doi = {10.1007/s10072-026-09166-2}
}
EUVIMED